glp 1 or mounjaro Could GLP-1 Weight Loss Drugs Also Treat Prevent Chronic Diseases? GLP-1 Agonists for Diabetes: Mounjaro

14.6% of the participants qualified for participation based on elevated filling pressures, 13.4% based on hospitalization for heart failure within 12 months in combination with ongoing diuretic treatment or echocardiographic abnormalities (or both), and 72.0% based on NT-proBNP levels plus echocardiographic abnormalities Median body weight and BMI of participants were 105.1 kg and 37.0kg/m 2 , respectively At baseline, patients had substantial degree of heart failure related symptoms, physical limitations, and poor exercise tolerance Outcomes Primary Outcome Co-primary endpoints for Semaglutide vs placebo from baseline to week 52: Change in KCCQ-CSS 16.6 points vs 8.7 points (estimated difference, 7.8 points

Finally, another meta-analysis by Monami et al

Gentle Carbohydrates Carbs are not the enemy on a GLP-1 medication

Fat loss and muscle loss happen in roughly equal proportions

People on GLP-1 medications can reference guides on foods to eat on semaglutide for fiber-rich meal ideas